Thus, the remainder of this review aims to highlight current knowledge of genes epigenetically regulated in cancer that are also involved in pathways critical for OV therapy, namely the IFN-mediated antiviral response and antigen presentation (Table 1), and how this contributes to tumor heterogeneity (Figure 1). The gene discussed is IFNA1; the disease is neoplasm.